These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Adami J; Frisch M; Yuen J; Glimelius B; Melbye M BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593 [TBL] [Abstract][Full Text] [Related]
68. Polymorphisms in folate-metabolizing genes and risk of non-Hodgkin's lymphoma. Weiner AS; Beresina OV; Voronina EN; Voropaeva EN; Boyarskih UA; Pospelova TI; Filipenko ML Leuk Res; 2011 Apr; 35(4):508-15. PubMed ID: 21055808 [TBL] [Abstract][Full Text] [Related]
69. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. Ngan BY; Chen-Levy Z; Weiss LM; Warnke RA; Cleary ML N Engl J Med; 1988 Jun; 318(25):1638-44. PubMed ID: 3287162 [TBL] [Abstract][Full Text] [Related]
70. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Correlation with histologic features in 36 cases. French Study Group of Pathology for HIV-Associated Tumors. Raphael MM; Audouin J; Lamine M; Delecluse HJ; Vuillaume M; Lenoir GM; Gisselbrecht C; Lennert K; Diebold J Am J Clin Pathol; 1994 Jun; 101(6):773-82. PubMed ID: 8209868 [TBL] [Abstract][Full Text] [Related]
71. Dendritic cells are significantly reduced in non-Hodgkin's lymphoma and express less CCR7 and CD62L. Fiore F; Von Bergwelt-Baildon MS; Drebber U; Beyer M; Popov A; Manzke O; Wickenhauser C; Baldus SE; Schultze JL Leuk Lymphoma; 2006 Apr; 47(4):613-22. PubMed ID: 16690519 [TBL] [Abstract][Full Text] [Related]
72. Epstein-Barr virus viral load and serology in childhood non-Hodgkin's lymphoma and chronic inflammatory conditions in Uganda: implications for disease risk and characteristics. Orem J; Sandin S; Mbidde E; Mangen FW; Middeldorp J; Weiderpass E J Med Virol; 2014 Oct; 86(10):1796-803. PubMed ID: 24889739 [TBL] [Abstract][Full Text] [Related]
73. Glucose-6-phosphate dehydrogenase polymorphism and lymphoma risk. Cocco P; Ennas MG; Melis MA; Sollaino C; Collu S; Fadda D; Gabbas A; Massarelli G; Rais M; Todde P; Angelucci E Tumori; 2007; 93(2):121-3. PubMed ID: 17557555 [TBL] [Abstract][Full Text] [Related]
74. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277 [TBL] [Abstract][Full Text] [Related]
75. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function? Hemminki K; Jiang Y; Steineck G Eur J Cancer; 2003 Jan; 39(2):223-9. PubMed ID: 12509955 [TBL] [Abstract][Full Text] [Related]
76. A polymorphism in the BCL-6 gene is associated with follicle center lymphoma. Lossos IS; Jones CD; Zehnder JL; Levy R Leuk Lymphoma; 2001; 42(6):1343-50. PubMed ID: 11911418 [TBL] [Abstract][Full Text] [Related]
77. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758 [TBL] [Abstract][Full Text] [Related]
78. Elevated frequency of the C2 allele of the ETS-I oncogene in elderly subjects. Crossen PE; Morrison MJ Mech Ageing Dev; 1996 Jul; 88(1-2):61-5. PubMed ID: 8803922 [TBL] [Abstract][Full Text] [Related]
79. Acetylation and oxidation phenotypes in malignant lymphoma. Philip PA; Rogers HJ; Harper PG Cancer Chemother Pharmacol; 1987; 20(3):235-8. PubMed ID: 3677298 [TBL] [Abstract][Full Text] [Related]